PUMA, a potent killer with or without p53

Oncogene

Volumn 27, Issue SUPPL. 1, 2008, Pages

  Yu, J ^a,b   Zhang, L ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Bcl 2 family; BH3 domain; P53; PUMA

Indexed keywords

BH3 PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; PUMA PROTEIN; TRANSCRIPTION FACTOR;

APOPTOSIS; CANCER RISK; CANCER THERAPY; CARCINOGENESIS; DEGENERATIVE DISEASE; GENOTOXICITY; INFECTION; MITOCHONDRION; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TISSUE INJURY;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CONSERVED SEQUENCE; DNA DAMAGE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION; HUMANS; INFECTION; MICE; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; NEOPLASMS; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; STRESS, PHYSIOLOGICAL; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 68149108384     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.45     Document Type: Review

References (156)

1. Adams JM, Cory S. (2007). The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26: 1324-1337.
2. Akhtar RS, Geng Y, Klocke BJ, Latham CB, Villunger A, Michalak EM et al. (2006). BH3-only proapoptotic Bcl-2 family members Noxa and Puma mediate neural precursor cell death. J Neurosci 26: 7257-7264.
3. Anding AL, Chapman JS, Barnett DW, Curley Jr RW, Clagett-Dame M. (2007). The unhydrolyzable fenretinide analogue 4-hydroxybenzylreti-none induces the proapoptotic genes GADD153 (CHOP) and Bcl-2-binding component 3 (PUMA) and apoptosis that is caspase-dependent and independent of the retinoic acid receptor. Cancer Res 67: 6270-6277.
4. Bauer A, Villunger A, Labi V, Fischer SF, Strasser A, Wagner H et al. (2006). The NF-kappaB regulator Bcl-3 and the BH3-only proteins Bim and Puma control the death of activated T cells. Proc Natl Acad Sci USA 103: 10979-10984.
5. Biswas SC, Ryu E, Park C, Malagelada C, Greene LA. (2005). Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease. Neurochem Res 30: 839-845.
6. Callus BA, Ekert PG, Heraud JE, Jabbour AM, Kotevski A, Vince JE et al. (2008). Cytoplasmic p53 is not required for PUMA-induced apoptosis. Cell Death Differ 15: 213-215; author reply 215-216.
7. Cartron PF, Gallenne T, Bougras G, Gautier F, Manero F, Vusio P et al. (2004). The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA. Mol Cell 16: 807-818.
8. Castedo M, Coquelle A, Vivet S, Vitale I, Kauffmann A, Dessen P et al. (2006). Apoptosis regulation in tetraploid cancer cells. EMBO J 25: 2584-2595.
9. Castedo M, Perfettini JL, Piacentini M, Kroemer G. (2005). p53-A pro-apoptotic signal transducer involved in AIDS. Biochem Biophys Res Commun 331: 701-706.
10. Chang KC, Unsinger J, Davis CG, Schwulst SJ, Muenzer JT, Strasser A et al. (2007). Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis. FASEB J 21: 708-719.
11. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG et al. (2005). Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17: 393-403.
12. Chen Y, Qian H, Wang H, Zhang X, Fu M, Liang X et al. (2007). Ad-PUMA sensitizes drug-resistant choriocarcinoma cells to chemotherapeutic agents. Gynecol Oncol 107: 505-512.
13. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR. (2005). PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309: 1732-1735.
14. Choy EY, Siu K, Kok K, Lung RW, Tsang CM, To K et al. (2008). An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 205: 2551-2560.
15. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML et al. (1993). Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852.
16. Concannon CG, Koehler BF, Reimertz C, Murphy BM, Bonner C, Thurow N et al. (2007). Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway. Oncogene 26: 1681-1692.
17. Cregan SP, Arbour NA, Maclaurin JG, Callaghan SM, Fortin A, Cheung EC et al. (2004). p53 activation domain 1 is essential for PUMA upregulation and p53-mediated neuronal cell death. J Neurosci 24: 10003-10012.
18. Cumont MC, Monceaux V, Viollet L, Lay S, Parker R, Hurtrel B et al. (2007). TGF-beta in intestinal lymphoid organs contributes to the death of armed effector CD8 T cells and is associated with the absence of virus containment in rhesus macaques infected with the simian immunodeficiency virus. Cell Death Differ 14: 1747-1758.
19. Day CL, Smits C, Fan FC, Lee EF, Fairlie WD, Hinds MG. (2008). Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1. J Mol Biol 380: 958-971.
20. de La Motte Rouge T, Galluzzi L, Olaussen KA, Zermati Y, Tasdemir E, Robert T et al. (2007). A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib. Cancer Res 67: 6253-6262.
21. Deng J, Carlson N, Takeyama K, Dal Cin P, Shipp M, Letai A. (2007). BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Cancer Cell 12: 171-185.
22. Ding WX, Ni HM, Chen X, Yu J, Zhang L, Yin XM. (2007). A coordinated action of Bax, PUMA, and p53 promotes MG132-induced mitochondria activation and apoptosis in colon cancer cells. Mol Cancer Ther 6: 1062-1069.
23. Dong F, Pirbhai M, Xiao Y, Zhong Y, Wu Y, Zhong G. (2005). Degradation of the proapoptotic proteins Bik, Puma, and Bim with Bcl-2 domain 3 homology in Chlamydia trachomatis-infected cells. Infect Immun 73: 1861-1864.
24. Dvory-Sobol H, Sagiv E, Liberman E, Kazanov D, Arber N. (2007). Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway. Cancer 109: 188-197.
25. Ekert PG, Jabbour AM, Manoharan A, Heraud JE, Yu J, Pakusch M et al. (2006). Cell death provoked by loss of interleukin-3 signaling is independent of Bad, Bim, and PI3 kinase, but depends in part on Puma. Blood 108: 1461-1468.
26. Ekoff M, Kaufmann T, Engstrom M, Motoyama N, Villunger A, Jonsson JI et al. (2007). The BH3-only protein Puma plays an essential role in cytokine deprivation induced apoptosis of mast cells. Blood 110: 3209-3217.
27. Erlacher M, Labi V, Manzl C, Bock G, Tzankov A, Hacker G et al. (2006). Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction. J Exp Med 203: 2939-2951.
28. Erlacher M, Michalak EM, Kelly PN, Labi V, Niederegger H, Coultas L et al. (2005). BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 106: 4131-4138.
29. Fei P, Bernhard EJ, El-Deiry WS. (2002). Tissue-specific induction of p53 targets in vivo. Cancer Res 62: 7316-7327.
30. Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J et al. (2003). Genomic targets of the human c-Myc protein. Genes Dev 17: 1115-1129.
31. Fischer SF, Belz GT, Strasser A. (2008). BH3-only protein Puma contributes to death of antigen-specific T cells during shutdown of an immune response to acute viral infection. Proc Natl Acad Sci USA 105: 3035-3040.
32. Fischer SF, Vier J, Kirschnek S, Klos A, Hess S, Ying S et al. (2004). Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3-only proteins. J Exp Med 200: 905-916.
33. Fujioka S, Schmidt C, Sclabas GM, Li Z, Pelicano H, Peng B et al. (2004). Stabilization of p53 is a novel mechanism for proapoptotic function of NF-kappaB. J Biol Chem 279: 27549-27559.
34. Futami T, Miyagishi M, Taira K. (2005). Identification of a network involved in thapsigargin-induced apoptosis using a library of small interfering RNA expression vectors. J Biol Chem 280: 826-831.
35. Garrison SP, Jeffers JR, Yang C, Nilsson JA, Hall MA, Rehg JE et al. (2008). Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis. Mol Cell Biol 28: 5391-5402.
36. Giannakakou P, Nakano M, Nicolaou KC, O'Brate A, Yu J, Blagosklonny MV et al. (2002). Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics. Proc Natl Acad Sci USA 99: 10855-10860.
37. Giladi N, Dvory-Sobol H, Sagiv E, Kazanov D, Liberman E, Arber N. (2007). Gene therapy approach in prostate cancer cells using an active Wnt signal. Biomed Pharmacother 61: 527-530.
38. Gomez-Benito M, Balsas P, Carvajal-Vergara X, Pandiella A, Anel A, Marzo I et al. (2007). Mechanism of apoptosis induced by IFN-alpha in human myeloma cells: role of Jak1 and Bim and potentiation by rapamycin. Cell Signal 19: 844-854.
39. Gomez-Benito M, Marzo I, Anel A, Naval J. (2005). Farnesyltransferase inhibitor BMS-214662 induces apoptosis in myeloma cells through PUMA up-regulation, Bax and Bak activation, and Mcl-1 elimination. Mol Pharmacol 67: 1991-1998.
40. Gomez-Lazaro M, Galindo MF, Fernandez-Gomez FJ, Prehn JH, Jordan J. (2005). Activation of p53 and the pro-apoptotic p53 target gene PUMA during depolarization-induced apoptosis of chromaffin cells. Exp Neurol 196: 96-103.
41. Han J, Flemington C, Houghton AB, Gu Z, Zambetti GP, Lutz RJ et al. (2001). Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc Natl Acad Sci USA 98: 11318-11323.
42. Hao H, Dong Y, Bowling MT, Gomez-Gutierrez JG, Zhou HS, McMasters KM. (2007). E2F-1 induces melanoma cell apoptosis via PUMA up-regulation and Bax translocation. BMC Cancer 7: 24.
43. Hayakawa J, Mittal S, Wang Y, Korkmaz KS, Adamson E, English C et al. (2004). Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. Mol Cell 16: 521-535.
44. Hemann MT, Zilfou JT, Zhao Z, Burgess DJ, Hannon GJ, Lowe SW. (2004). Suppression of tumorigenesis by the p53 target PUMA. Proc Natl Acad Sci USA 101: 9333-9338.
45. Hermeking H, Eick D. (1994). Mediation of c-Myc-induced apoptosis by p53. Science 265: 2091-2093.
46. Hershko T, Ginsberg D. (2004). Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J Biol Chem 279: 8627-8634.
47. Hetz C, Thielen P, Fisher J, Pasinelli P, Brown RH, Korsmeyer S et al. (2007). The proapoptotic BCL-2 family member BIM mediates motoneuron loss in a model of amyotrophic lateral sclerosis. Cell Death Differ 14: 1386-1389.
48. Hoque MO, Begum S, Sommer M, Lee T, Trink B, Ratovitski E et al. (2003). PUMA in head and neck cancer. Cancer Lett 199: 75-81.
49. Horvitz HR. (1999). Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Res 59: 1701s-1706s.
50. Ishihara T, Hoshino T, Namba T, Tanaka K, Mizushima T. (2007). Involvement of up-regulation of PUMA in non-steroidal anti-inflammatory drug-induced apoptosis. Biochem Biophys Res Commun 356: 711-717.
51. Ito H, Kanzawa T, Miyoshi T, Hirohata S, Kyo S, Iwamaru A et al. (2005). Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status. Hum Gene Ther 16: 685-698.
52. Iyer NG, Chin SF, Ozdag H, Daigo Y, Hu DE, Cariati M et al. (2004). p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels. Proc Natl Acad Sci USA 101: 7386-7391.
53. Jackson JG, Pereira-Smith OM. (2006). p53 is preferentially recruited to the promoters of growth arrest genes p21 and GADD45 during replicative senescence of normal human fibroblasts. Cancer Res 66: 8356-8360.
54. Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J et al. (2003). Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4: 321-328.
55. Jiang CC, Lucas K, Avery-Kiejda KA, Wade M, deBock CE, Thorne RF et al. (2008). Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress. Cancer Res 68: 6708-6717.
56. Johnstone RW, Ruefli AA, Lowe SW. (2002). Apoptosis: a link between cancer genetics and chemotherapy. Cell 108: 153-164.
57. Kaeser MD, Iggo RD. (2002). Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc Natl Acad Sci USA 99: 95-100.
58. Kaeser MD, Pebernard S, Iggo RD. (2004). Regulation of p53 stability and function in HCT116 colon cancer cells. J Biol Chem 279: 7598-7605.
59. Kalousek I, Brodska B, Otevrelova P, Roselova P. (2007). Actinomycin D upregulates proapoptotic protein Puma and downregulates Bcl-2 mRNA in normal peripheral blood lymphocytes. Anticancer Drugs 18: 763-772.
60. Karst AM, Dai DL, Cheng JQ, Li G. (2006). Role of p53 up-regulated modulator of apoptosis and phosphorylated Akt in melanoma cell growth, apoptosis, and patient survival. Cancer Res 66: 9221-9226.
61. Karst AM, Dai DL, Martinka M, Li G. (2005). PUMA expression is significantly reduced in human cutaneous melanomas. Oncogene 24: 1111-1116.
62. Kieran D, Woods I, Villunger A, Strasser A, Prehn JH. (2007). Deletion of the BH3-only protein puma protects motoneurons from ER stress-induced apoptosis and delays motoneuron loss in ALS mice. Proc Natl Acad Sci USA 104: 20606-20611.
63. Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJ et al. (2006). Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 8: 1348-1358.
64. Kim MR, Jeong EG, Chae B, Lee JW, Soung YH, Nam SW et al. (2007). Pro-apoptotic PUMA and anti-apoptotic phospho-BAD are highly expressed in colorectal carcinomas. Dig Dis Sci 52: 2751-2756.
65. Klanrit P, Flinterman MB, Odell EW, Melino G, Killick R, Norris JS et al. (2008). Specific isoforms of p73 control the induction of cell death induced by the viral proteins, E1A or apoptin. Cell Cycle 7: 205-215.
66. Koutsodontis G, Vasilaki E, Chou WC, Papakosta P, Kardassis D. (2005). Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis. Biochem J 389: 443-455.
67. Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, Green DR et al. (2005). BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 17: 525-535.
68. Lakhani SA, Masud A, Kuida K, Porter Jr GA, Booth CJ, Mehal WZ et al. (2006). Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311: 847-851.
69. Le HV, Minn AJ, Massague J. (2005). Cyclin-dependent kinase inhibitors uncouple cell cycle progression from mitochondrial apoptotic functions in DNA-damaged cancer cells. J Biol Chem 280: 32018-32025.
70. Lee DH, Kim C, Zhang L, Lee YJ. (2008). Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells. Biochem Pharmacol 75: 2020-2033.
71. Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ. (2002). Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2: 183-192.
72. Li J, Lee B, Lee AS. (2006). Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53. J Biol Chem 281: 7260-7270.
73. Li YZ, Lu DY, Tan WQ, Wang JX, Li PF. (2008). p53 initiates apoptosis by transcriptionally targeting the antiapoptotic protein ARC. Mol Cell Biol 28: 564-574.
74. Liu HF, Hsiao PW, Chao JI. (2008). Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells. Chem Biol Interact 176: 48-57.
75. Liu Z, Lu H, Shi H, Du Y, Yu J, Gu S et al. (2005). PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells. Cancer Res 65: 1647-1654.
76. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. (1993). p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849.
77. Luo X, He Q, Huang Y, Sheikh MS. (2005). Transcriptional upregulation of PUMA modulates endoplasmic reticulum calcium pool depletion-induced apoptosis via Bax activation. Cell Death Differ 12: 1310-1318.
78. Macip S, Igarashi M, Berggren P, Yu J, Lee SW, Aaronson SA. (2003). Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol Cell Biol 23: 8576-8585.
79. Maclean KH, Keller UB, Rodriguez-Galindo C, Nilsson JA, Cleveland JL. (2003). c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL. Mol Cell Biol 23: 7256-7270.
80. Matallanas D, Romano D, Yee K, Meissl K, Kucerova L, Piazzolla D et al. (2007). RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol Cell 27: 962-975.
81. Melino G, Bernassola F, Ranalli M, Yee K, Zong WX, Corazzari M et al. (2004). p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J Biol Chem 279: 8076-8083.
82. Meng Y, Tang W, Dai Y, Wu X, Liu M, Ji Q et al. (2008). Natural
83. BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa. Mol Cancer Ther 7: 2192-2202.
84. Michalak EM, Villunger A, Adams JM, Strasser A. (2008). In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute. Cell Death Differ 15: 1019-1029.
85. Middelburg R, de Haas RR, Dekker H, Kerkhoven RM, Pohlmann PR, Fuentes-Alburo A et al. (2005). Induction of p53 up-regulated modulator of apoptosis messenger RNA by chemotherapeutic treatment of locally advanced breast cancer. Clin Cancer Res 11: 1863-1869.
86. Ming L, Sakaida T, Yue W, Jha A, Zhang L, Yu J. (2008). Sp1 and p73 activate PUMA following serum starvation. Carcinogenesis 29: 1878-1884.
87. Ming L, Wang P, Bank A, Yu J, Zhang L. (2006). PUMA dissociates Bax and Bcl-X(L) to induce apoptosis in colon cancer cells. J Biol Chem 281: 16034-16042.
88. Morales AA, Gutman D, Lee KP, Boise LH. (2008). BH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide-induced cell death in myeloma. Blood 111: 5152-5162.
89. Naik E, Michalak EM, Villunger A, Adams JM, Strasser A. (2007). Ultraviolet radiation triggers apoptosis of fibroblasts and skin keratinocytes mainly via the BH3-only protein Noxa. J Cell Biol 176: 415-424.
90. Nakano K, Vousden KH. (2001). PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7: 683-694.
91. Nardacci R, Antinori A, Larocca LM, Arena V, Amendola A, Perfettini JL et al. (2005). Characterization of cell death pathways in human immunodeficiency virus-associated encephalitis. Am J Pathol 167: 695-704.
92. Nelson DA, Tan TT, Rabson AB, Anderson D, Degenhardt K, White E. (2004). Hypoxia and defective apoptosis drive genomic instability and tumorigenesis. Genes Dev 18: 2095-2107.
93. Nickson P, Toth A, Erhardt P. (2007). PUMA is critical for neonatal cardiomyocyte apoptosis induced by endoplasmic reticulum stress. Cardiovasc Res 73: 48-56.
94. Noguchi KK, Walls KC, Wozniak DF, Olney JW, Roth KA, Farber NB. (2008). Acute neonatal glucocorticoid exposure produces selective and rapid cerebellar neural progenitor cell apoptotic death. Cell Death Differ 15: 1582-1592.
95. Nyman U, Sobczak-Pluta A, Vlachos P, Perlmann T, Zhivotovsky B, Joseph B. (2005). Full-length p73alpha represses drug-induced apoptosis in small cell lung carcinoma cells. J Biol Chem 280: 34159-34169.
96. Patel S, George R, Autore F, Fraternali F, Ladbury JE, Nikolova PV. (2008). Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax. Nucleic Acids Res 36: 5139-5151.
97. Perfettini JL, Roumier T, Castedo M, Larochette N, Boya P, Raynal B et al. (2004). NF-kappaB and p53 are the dominant apoptosis-inducing transcription factors elicited by the HIV-1 envelope. J Exp Med 199: 629-640.
98. Puthalakath H, O'Reilly LA, Gunn P, Lee L, Kelly PN, Huntington ND et al. (2007). ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 129: 1337-1349.
99. Qiao L, Han SI, Fang Y, Park JS, Gupta S, Gilfor D et al. (2003). Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes. Mol Cell Biol 23: 3052-3066.
100. Qiu W, Carson-Walter EB, Liu H, Epperly M, Greenberger JS, Zambetti GP et al. (2008). PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell 2: 576-583.
101. Rao RV, Niazi K, Mollahan P, Mao X, Crippen D, Poksay KS et al. (2006). Coupling endoplasmic reticulum stress to the cell-death program: a novel HSP90-independent role for the small chaperone protein p23. Cell Death Differ 13: 415-425.
102. Reimertz C, Kogel D, Rami A, Chittenden T, Prehn JH. (2003). Gene expression during ER stress-induced apoptosis in neurons: induction of the BH3-only protein Bbc3/PUMA and activation of the mitochondrial apoptosis pathway. J Cell Biol 162: 587-597.
103. Rocco JW, Leong CO, Kuperwasser N, DeYoung MP, Ellisen LW. (2006). p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 9: 45-56.
104. Rushton JJ, Davis LM, Lei W, Mo X, Leutz A, Ness SA. (2003). Distinct changes in gene expression induced by A-Myb, B-Myb and c-Myb proteins. Oncogene 22: 308-313.
105. Schumm K, Rocha S, Caamano J, Perkins ND. (2006). Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit. EMBO J 25: 4820-4832.
106. Seoane J, Le HV, Massague J. (2002). Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419: 729-734.
107. Shaltouki A, Freer M, Mei Y, Weyman CM. (2007). Increased expression of the pro-apoptotic Bcl2 family member PUMA is required for mitochondrial release of cytochrome c and the apoptosis associated with skeletal myoblast differentiation. Apoptosis 12: 2143-2154.
108. Shibue T, Suzuki S, Okamoto H, Yoshida H, Ohba Y, Takaoka A et al. (2006). Differential contribution of Puma and Noxa in dual regulation of p53-mediated apoptotic pathways. EMBO J 25: 4952-4962.
109. Sidi S, Sanda T, Kennedy RD, Hagen AT, Jette CA, Hoffmans R et al. (2008). Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. Cell 133: 864-877.
110. Simoes-Wust AP, Sigrist B, Belyanskaya L, Hopkins Donaldson S, Stahel RA, Zangemeister-Wittke U. (2005). DeltaNp73 antisense activates PUMA and induces apoptosis in neuroblastoma cells. J Neurooncol 72: 29-34.
111. Sinicrope FA, Rego RL, Okumura K, Foster NR, O'Connell MJ, Sargent DJ et al. (2008). Prognostic impact of bim, puma, and noxa expression in human colon carcinomas. Clin Cancer Res 14: 5810-5818.
112. Smits C, Czabotar PE, Hinds MG, Day CL. (2008). Structural plasticity underpins promiscuous binding of the prosurvival protein A1. Structure 16: 818-829.
113. Stanelle J, Putzer BM. (2006). E2F1-induced apoptosis: turning killers into therapeutics. Trends Mol Med 12: 177-185.
114. Steckley D, Karajgikar M, Dale LB, Fuerth B, Swan P, Drummond-Main C et al. (2007). Puma is a dominant regulator of oxidative stress induced Bax activation and neuronal apoptosis. J Neurosci 27: 12989-12999.
115. Steele AJ, Prentice AG, Hoffbrand AV, Yogashangary BC, Hart SM, Nacheva EP et al. (2008). p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism. Blood 112: 3827-3834.
116. Strom E, Sathe S, Komarov PG, Chernova OB, Pavlovska I, Shyshynova I et al. (2006). Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat Chem Biol 2: 474-479.
117. Sun Q, Sakaida T, Yue W, Gollin SM, Yu J. (2007). Chemosensitization of head and neck cancer cells by PUMA. Mol Cancer Ther 6: 3180-3188.
118. Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS et al. (2006). Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 24: 841-851.
119. Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H et al. (2003). Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 424: 516-523.
120. Tategu M, Arauchi T, Tanaka R, Nakagawa H, Yoshida K. (2008). Puma is a novel target of soy isoflavone genistein but is dispensable for genistein-induced cell fate determination. Mol Nutr Food Res 52: 439-446.
121. Toth A, Jeffers JR, Nickson P, Min JY, Morgan JP, Zambetti GP et al. (2006). Targeted deletion of Puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion. Am J Physiol Heart Circ Physiol 291: H52-H60.
122. Tsuruya K, Yotsueda H, Ikeda H, Taniguchi M, Masutani K, Hayashida H et al. (2008). Involvement of p53-transactivated Puma in cisplatin-induced renal tubular cell death. Life Sci 83: 550-556.
123. van Delft MF, Wei AH, Mason KD, Vandenberg CJ, Chen L, Czabotar PE et al. (2006). The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 10: 389-399.
124. Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, Ausserlechner MJ et al. (2003). p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302: 1036-1038.
125. Vogelstein B, Kinzler KW. (2004). Cancer genes and the pathways they control. Nat Med 10: 789-799.
126. Wang H, Qian H, Yu J, Zhang X, Zhang L, Fu M et al. (2006). Administration of PUMA adenovirus increases the sensitivity of esophageal cancer cells to anticancer drugs. Cancer Biol Ther 5: 380-385.
127. Wang P, Yu J, Zhang L. (2007a). The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage. Proc Natl Acad Sci USA 104: 4054-4059.
128. Wang R, Wang X, Li B, Lin F, Dong K, Gao P et al. (2008a). Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo. Breast Cancer Res Treat 2008; e-pub ahead of print 13 September 2008.
129. Wang X, Wang R, Hao MW, Dong K, Wei SH, Lin F et al. (2008b). The BH3-only protein PUMA is involved in green tea polyphenol-induced apoptosis in colorectal cancer cell lines. Cancer Biol Ther 7: 902-908.
130. Wang YF, Jiang CC, Kiejda KA, Gillespie S, Zhang XD, Hersey P. (2007b). Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1. Clin Cancer Res 13: 4934-4942.
131. Ward MW, Kogel D, Prehn JH. (2004). Neuronal apoptosis: BH3-only proteins the real killers? J Bioenerg Biomembr 36: 295-298.
132. Webster KA. (2006). Puma joins the battery of BH3-only proteins that promote death and infarction during myocardial ischemia. Am J Physiol Heart Circ Physiol 291: H20-H22.
133. Wei J, O'Brien D, Vilgelm A, Piazuelo MB, Correa P, Washington MK et al. (2008). Interaction of Helicobacter pylori with gastric epithelial cells is mediated by the p53 protein family. Gastroenterology 134: 1412-1423.
134. Willis SN, Fletcher JI, Kaufmann T, van Delft MF, Chen L, Czabotar PE et al. (2007). Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315: 856-859.
135. Wolff S, Erster S, Palacios G, Moll UM. (2008). p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity. Cell Res 18: 733-744.
136. Wong HK, Fricker M, Wyttenbach A, Villunger A, Michalak EM, Strasser A et al. (2005). Mutually exclusive subsets of BH3-only proteins are activated by the p53 and c-Jun N-terminal kinase/c-Jun signaling pathways during cortical neuron apoptosis induced by arsenite. Mol Cell Biol 25: 8732-8747.
137. Wu B, Qiu W, Wang P, Yu H, Cheng T, Zambetti GP et al. (2007). p53 independent induction of PUMA mediates intestinal apoptosis in response to ischaemia-reperfusion. Gut 56: 645-654.
138. Wu WS, Heinrichs S, Xu D, Garrison SP, Zambetti GP, Adams JM et al. (2005). Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 123: 641-653.
139. Wyttenbach A, Tolkovsky AM. (2006). The BH3-only protein Puma is both necessary and sufficient for neuronal apoptosis induced by DNA damage in sympathetic neurons. J Neurochem 96: 1213-1226.
140. Xu B, Wang BJ, Li AM, Lock R. (2006). [Effect of glucocorticoid on the expression of Puma in acute lymphoblastic leukemia]. Zhongguo Dang Dai Er Ke Za Zhi 8: 151-154.
141. Yee KS, Vousden KH. (2008). Contribution of membrane localization to the apoptotic activity of PUMA. Apoptosis 13: 87-95.
142. Ying S, Seiffert BM, Hacker G, Fischer SF. (2005). Broad degradation of proapoptotic proteins with the conserved Bcl-2 homology domain 3 during infection with Chlamydia trachomatis. Infect Immun 73: 1399-1403.
143. Yoo NJ, Lee JW, Jeong EG, Lee SH. (2007). Immunohisto-chemical analysis of pro-apoptotic PUMA protein and mutational analysis of PUMA gene in gastric carcinomas. Dig Liver Dis 39: 222-227.
144. You H, Pellegrini M, Tsuchihara K, Yamamoto K, Hacker G, Erlacher M et al. (2006a). FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal. J Exp Med 203: 1657-1663.
145. You H, Yamamoto K, Mak TW. (2006b). Regulation of transactivation- independent proapoptotic activity of p53 by FOXO3a. Proc Natl Acad Sci USA 103: 9051-9056.
146. Yu J, Tiwari S, Steiner P, Zhang L. (2003a). Differential apoptotic response to the proteasome inhibitor Bortezomib [VELCADE, PS-341] in Bax-deficient and p21-deficient colon cancer cells. Cancer Biol Ther 2: 694-699.
147. Yu J, Wang P, Ming L, Wood MA, Zhang L. (2007). SMAC/
148. Diablo mediates the proapoptotic function of PUMA by regulating PUMA-induced mitochondrial events. Oncogene 26: 4189-4198.
149. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L. (2003b). PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci USA 100: 1931-1936.
150. Yu J, Yue W, Wu B, Zhang L. (2006). PUMA sensitizes lung cancer cells to chemotherapeutic agents and irradiation. Clin Cancer Res 12: 2928-2936.
151. Yu J, Zhang L. (2005). The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 331: 851-858.
152. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B. (2001). PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 7: 673-682.
153. Zeng H, Carlson AQ, Guo Y, Yu Y, Collier-Hyams LS, Madara JL et al. (2003). Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella. J Immunol 171: 3668-3674.
154. Zhang D, Zaugg K, Mak TW, Elledge SJ. (2006). A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response. Cell 126: 529-542.
155. Zhang L, Ming L, Yu J. (2007). BH3 mimetics to improve cancer therapy; mechanisms and examples. Drug Resist Updat 10: 207-217.
156. Zou CG, Cao XZ, Zhao YS, Gao SY, Li SD, Liu XY et al. (2008). The molecular mechanism of endoplasmic reticulum stress-induced apoptosis in PC-12 neuronal cells: the protective effect of insulin-like growth factor-1. Endocrinology 150: 277-285.